nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.0533	0.0741	CcSEcCtD
Abiraterone—SULT2A1—Sulfation Biotransformation Reaction—GSR—amyotrophic lateral sclerosis	0.0377	0.134	CbGpPWpGaD
Abiraterone—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0339	0.0472	CcSEcCtD
Abiraterone—SULT2A1—E2F transcription factor network—UXT—amyotrophic lateral sclerosis	0.0307	0.109	CbGpPWpGaD
Abiraterone—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.0294	0.0409	CcSEcCtD
Abiraterone—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.0288	0.0401	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.0273	0.0379	CcSEcCtD
Abiraterone—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.0259	0.036	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.0228	0.0317	CcSEcCtD
Abiraterone—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.0203	0.0282	CcSEcCtD
Abiraterone—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.018	0.0251	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0178	0.0248	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0175	0.0243	CcSEcCtD
Abiraterone—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.0158	0.022	CcSEcCtD
Abiraterone—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.0153	0.0213	CcSEcCtD
Abiraterone—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0153	0.0212	CcSEcCtD
Abiraterone—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0153	0.0212	CcSEcCtD
Abiraterone—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.015	0.0209	CcSEcCtD
Abiraterone—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0208	CcSEcCtD
Abiraterone—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0206	CcSEcCtD
Abiraterone—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.0145	0.0202	CcSEcCtD
Abiraterone—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0188	CcSEcCtD
Abiraterone—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0187	CcSEcCtD
Abiraterone—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.0134	0.0187	CcSEcCtD
Abiraterone—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0177	CcSEcCtD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—CASP12—amyotrophic lateral sclerosis	0.0124	0.0442	CbGpPWpGaD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—ECE1—amyotrophic lateral sclerosis	0.0124	0.0442	CbGpPWpGaD
Abiraterone—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0173	CcSEcCtD
Abiraterone—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0123	0.0172	CcSEcCtD
Abiraterone—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.0122	0.017	CcSEcCtD
Abiraterone—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.012	0.0167	CcSEcCtD
Abiraterone—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.011	0.0153	CcSEcCtD
Abiraterone—Cough—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0145	CcSEcCtD
Abiraterone—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0143	CcSEcCtD
Abiraterone—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0141	CcSEcCtD
Abiraterone—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0141	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0101	0.014	CcSEcCtD
Abiraterone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.01	0.014	CcSEcCtD
Abiraterone—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00973	0.0135	CcSEcCtD
Abiraterone—Infection—Riluzole—amyotrophic lateral sclerosis	0.00966	0.0134	CcSEcCtD
Abiraterone—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00945	0.0131	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00886	0.0123	CcSEcCtD
Abiraterone—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.0088	0.0122	CcSEcCtD
Abiraterone—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00867	0.0121	CcSEcCtD
Abiraterone—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00856	0.0119	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0084	0.0117	CcSEcCtD
Abiraterone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00839	0.0117	CcSEcCtD
Abiraterone—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00832	0.0116	CcSEcCtD
Abiraterone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00769	0.0107	CcSEcCtD
Abiraterone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00698	0.00971	CcSEcCtD
Abiraterone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00665	0.00926	CcSEcCtD
Abiraterone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—TPK1—amyotrophic lateral sclerosis	0.00647	0.023	CbGpPWpGaD
Abiraterone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00618	0.00861	CcSEcCtD
Abiraterone—Rash—Riluzole—amyotrophic lateral sclerosis	0.00613	0.00853	CcSEcCtD
Abiraterone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00613	0.00853	CcSEcCtD
Abiraterone—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.00592	0.021	CbGpPWpGaD
Abiraterone—SULT2A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00584	0.0208	CbGpPWpGaD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—CASP9—amyotrophic lateral sclerosis	0.00492	0.0175	CbGpPWpGaD
Abiraterone—CYP2D6—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.0045	0.016	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.0045	0.016	CbGpPWpGaD
Abiraterone—SULT2A1—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.00447	0.0159	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00411	0.0146	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00382	0.0136	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00359	0.0128	CbGpPWpGaD
Abiraterone—CYP17A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.0031	0.011	CbGpPWpGaD
Abiraterone—SULT2A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00261	0.00929	CbGpPWpGaD
Abiraterone—SULT2A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00258	0.00916	CbGpPWpGaD
Abiraterone—ABCC1—S1P1 pathway—PTGS2—amyotrophic lateral sclerosis	0.00253	0.00897	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00246	0.00875	CbGpPWpGaD
Abiraterone—ALB—HDL-mediated lipid transport—APOE—amyotrophic lateral sclerosis	0.00242	0.00859	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00239	0.00848	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00218	0.00775	CbGpPWpGaD
Abiraterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00211	0.0075	CbGpPWpGaD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—CASP3—amyotrophic lateral sclerosis	0.00207	0.00737	CbGpPWpGaD
Abiraterone—ABCC1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00207	0.00734	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00203	0.00721	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.002	0.00712	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.002	0.00712	CbGpPWpGaD
Abiraterone—ABCC1—S1P1 pathway—VEGFA—amyotrophic lateral sclerosis	0.00199	0.00707	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	0.00197	0.00701	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00191	0.00678	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	0.00188	0.00668	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00187	0.00663	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00183	0.00651	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.00178	0.00631	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.00176	0.00625	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.0017	0.00605	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.00169	0.00601	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.0016	0.00569	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.00145	0.00514	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00144	0.00511	CbGpPWpGaD
Abiraterone—ALB—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.00139	0.00493	CbGpPWpGaD
Abiraterone—CYP17A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00139	0.00493	CbGpPWpGaD
Abiraterone—CYP17A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00137	0.00486	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00132	0.00468	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00131	0.00465	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.00123	0.00437	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00122	0.00435	CbGpPWpGaD
Abiraterone—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00118	0.00419	CbGpPWpGaD
Abiraterone—ABCC1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.00116	0.00414	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00115	0.00409	CbGpPWpGaD
Abiraterone—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00113	0.00401	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.0011	0.0039	CbGpPWpGaD
Abiraterone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.00108	0.00384	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00106	0.00378	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00106	0.00378	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00104	0.00369	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00102	0.00363	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.00101	0.0036	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.001	0.00356	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000991	0.00352	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000972	0.00345	CbGpPWpGaD
Abiraterone—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000923	0.00328	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000922	0.00328	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000908	0.00323	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000904	0.00321	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000875	0.00311	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000859	0.00305	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00085	0.00302	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000838	0.00298	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000832	0.00295	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000818	0.00291	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000795	0.00283	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000789	0.0028	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000788	0.0028	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000786	0.00279	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000782	0.00278	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000768	0.00273	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TPK1—amyotrophic lateral sclerosis	0.000765	0.00272	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000759	0.0027	CbGpPWpGaD
Abiraterone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—amyotrophic lateral sclerosis	0.000748	0.00266	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000719	0.00255	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000715	0.00254	CbGpPWpGaD
Abiraterone—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000714	0.00254	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000668	0.00238	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000668	0.00237	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000665	0.00236	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000651	0.00231	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000641	0.00228	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000641	0.00228	CbGpPWpGaD
Abiraterone—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000636	0.00226	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000628	0.00223	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000625	0.00222	CbGpPWpGaD
Abiraterone—ABCC1—Disease—VTA1—amyotrophic lateral sclerosis	0.000612	0.00217	CbGpPWpGaD
Abiraterone—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000607	0.00216	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000598	0.00212	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000586	0.00208	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000582	0.00207	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000568	0.00202	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000568	0.00202	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000563	0.002	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000548	0.00195	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000545	0.00194	CbGpPWpGaD
Abiraterone—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000541	0.00192	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000537	0.00191	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000524	0.00186	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.00052	0.00185	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000512	0.00182	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000507	0.0018	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000499	0.00177	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000489	0.00174	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000464	0.00165	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000463	0.00165	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000457	0.00162	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000451	0.0016	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000451	0.0016	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000447	0.00159	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000441	0.00157	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000431	0.00153	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000428	0.00152	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PLB1—amyotrophic lateral sclerosis	0.000419	0.00149	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000419	0.00149	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000411	0.00146	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000406	0.00144	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000403	0.00143	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000402	0.00143	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000381	0.00135	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000375	0.00133	CbGpPWpGaD
Abiraterone—ABCC1—Disease—VCP—amyotrophic lateral sclerosis	0.000374	0.00133	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00037	0.00131	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000363	0.00129	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000351	0.00125	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00035	0.00124	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00035	0.00124	CbGpPWpGaD
Abiraterone—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000348	0.00124	CbGpPWpGaD
Abiraterone—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000348	0.00124	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.000342	0.00122	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000342	0.00121	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000338	0.0012	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000326	0.00116	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.000326	0.00116	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000325	0.00115	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000324	0.00115	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00032	0.00114	CbGpPWpGaD
Abiraterone—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000318	0.00113	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000309	0.0011	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000309	0.0011	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000301	0.00107	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000298	0.00106	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000296	0.00105	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000295	0.00105	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000287	0.00102	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000287	0.00102	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00028	0.000994	CbGpPWpGaD
Abiraterone—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000278	0.000989	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000276	0.00098	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000275	0.000977	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CST3—amyotrophic lateral sclerosis	0.000268	0.000953	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000266	0.000946	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000263	0.000934	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	0.000253	0.000899	CbGpPWpGaD
Abiraterone—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	0.000252	0.000894	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000245	0.000871	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000244	0.000868	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000243	0.000863	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000242	0.000859	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000237	0.000843	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000232	0.000825	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000232	0.000823	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00023	0.000816	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000218	0.000774	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	0.000208	0.000738	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000196	0.000697	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CASP9—amyotrophic lateral sclerosis	0.000195	0.000693	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000192	0.000682	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000191	0.000678	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000188	0.000668	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000188	0.000668	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000179	0.000637	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	0.000177	0.000629	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000176	0.000626	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	0.000176	0.000625	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000172	0.000611	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ERBB4—amyotrophic lateral sclerosis	0.000167	0.000593	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000166	0.000591	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000161	0.000573	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00016	0.00057	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00016	0.000568	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000157	0.00056	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000152	0.000539	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00015	0.000534	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000145	0.000517	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	0.000145	0.000516	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000145	0.000514	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000143	0.000508	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000136	0.000483	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000133	0.000471	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000132	0.000469	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000131	0.000467	CbGpPWpGaD
Abiraterone—ABCC1—Disease—APOE—amyotrophic lateral sclerosis	0.000129	0.000459	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000123	0.000437	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.00012	0.000425	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000119	0.000424	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000108	0.000384	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000103	0.000366	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	9.5e-05	0.000338	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.09e-05	0.000323	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.04e-05	0.000321	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTGS2—amyotrophic lateral sclerosis	8.85e-05	0.000314	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	7.82e-05	0.000278	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.81e-05	0.000278	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	7.8e-05	0.000277	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.77e-05	0.000276	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.41e-05	0.000263	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.18e-05	0.000255	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.14e-05	0.000254	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.41e-05	0.000228	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	5.91e-05	0.00021	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	5.91e-05	0.00021	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.89e-05	0.000209	CbGpPWpGaD
Abiraterone—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	5.87e-05	0.000209	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	4.85e-05	0.000172	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.19e-05	0.000149	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.05e-05	0.000144	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.02e-05	0.000143	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.85e-05	0.000137	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.32e-05	0.000118	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.17e-05	0.000113	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.17e-05	7.72e-05	CbGpPWpGaD
